• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估多个多基因风险评分以估计心肌梗死和冠状动脉病变的风险。

Appraisal of multiple polygenic risk scores to estimate the risk of myocardial infarction and coronary artery lesions.

作者信息

Manikpurage Hasanga D, Bourgault Jérôme, Houessou Ursula, Paulin Audrey, Zamani Pardis, Gagnon Eloi, Li Zhonglin, Boudreau Dominique K, Eslami Aida, Voisine Pierre, Mathieu Patrick, Bossé Yohan, Arsenault Benoit J, Thériault Sébastien

机构信息

Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Québec - Université Laval, Québec, QC, Canada.

Department of Social and Preventive Medicine, Faculty of Medicine, Université Laval, Québec, QC, Canada.

出版信息

Commun Med (Lond). 2025 Jul 1;5(1):264. doi: 10.1038/s43856-025-00981-w.

DOI:10.1038/s43856-025-00981-w
PMID:40593158
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12216164/
Abstract

BACKGROUND

Polygenic risk scores (PRS) could help to identify individuals with a high genetic risk profile for coronary artery disease (CAD). We aimed to evaluate the association between previously reported PRS and myocardial infarction (MI) as well as the extent and recurrence of coronary artery lesions.

METHODS

We validated previously reported CAD-PRS and 6 cardiovascular (CV) risk factors PRS (systolic blood pressure [SBP], type 2 diabetes [T2D], body-mass index [BMI], low-density lipoprotein cholesterol [LDL], triglycerides [TG], and lipoprotein-[a][Lp(a)]) in individuals of European ancestry from two Canadian population-based cohorts, the Canadian Longitudinal Study on Aging (CLSA, N = 24,599) and CARTaGENE (N = 26,806). Using a stepwise model, we determined an optimal combination of PRS to identify MI. We tested the selected PRS for association with the severity and recurrence of atherosclerotic CAD evaluated by coronary angiography in patients undergoing cardiac surgery (QUEBEC-ANGIO, N = 4108).

RESULTS

We show that the CAD-PRS most strongly associated with MI has odds ratios per standard deviation increment of 1.75 [1.64-1.86] (P = 1.57E-70) in CLSA and 1.87 [1.73-2.03] (P = 3.06E-53) in CARTaGENE. In CLSA, the optimal model includes CAD-PRS, SBP-PRS, BMI-PRS, LDL-PRS, TG-PRS and Lp(a)-PRS. Adding these PRS increases modestly yet significantly the discriminative capacity when compared to traditional risk factors (difference of AUC = 0.025 [0.019-0.031] in CLSA, 0.018 [0.012-0.024] in CARTaGENE). In QUEBEC-ANGIO, the CAD-PRS is gradually and significantly associated with the extent and recurrence of CAD.

CONCLUSIONS

Screening multiple validated PRS may significantly improve genetic risk estimation of MI as well as the extent and recurrence of coronary artery lesions.

摘要

背景

多基因风险评分(PRS)有助于识别冠状动脉疾病(CAD)遗传风险较高的个体。我们旨在评估先前报道的PRS与心肌梗死(MI)之间的关联,以及冠状动脉病变的程度和复发情况。

方法

我们在来自加拿大两个基于人群队列的欧洲血统个体中验证了先前报道的CAD-PRS和6种心血管(CV)危险因素PRS(收缩压[SBP]、2型糖尿病[T2D]、体重指数[BMI]、低密度脂蛋白胆固醇[LDL]、甘油三酯[TG]和脂蛋白[a][Lp(a)]),即加拿大老龄化纵向研究(CLSA,N = 24,599)和CARTaGENE(N = 26,806)。使用逐步模型,我们确定了用于识别MI的PRS的最佳组合。我们在接受心脏手术的患者(魁北克血管造影研究,N = 4108)中测试了所选PRS与通过冠状动脉造影评估的动脉粥样硬化性CAD的严重程度和复发之间的关联。

结果

我们发现,与MI最密切相关的CAD-PRS在CLSA中每标准差增加的比值比为1.75[1.64 - 1.86](P = 1.57E-70),在CARTaGENE中为1.87[1.73 - 2.03](P = 3.06E-53)。在CLSA中,最佳模型包括CAD-PRS、SBP-PRS、BMI-PRS、LDL-PRS、TG-PRS和Lp(a)-PRS。与传统危险因素相比,添加这些PRS可适度但显著提高判别能力(CLSA中AUC差异为0.025[0.019 - 0.031],CARTaGENE中为0.018[0.012 - 0.024])。在魁北克血管造影研究中,CAD-PRS与CAD的程度和复发逐渐且显著相关。

结论

筛查多个经过验证的PRS可能会显著改善MI的遗传风险估计以及冠状动脉病变的程度和复发情况。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ffa/12216164/c6e58a14770d/43856_2025_981_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ffa/12216164/e78774df87f4/43856_2025_981_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ffa/12216164/d8416dd3f0a6/43856_2025_981_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ffa/12216164/c6e58a14770d/43856_2025_981_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ffa/12216164/e78774df87f4/43856_2025_981_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ffa/12216164/d8416dd3f0a6/43856_2025_981_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ffa/12216164/c6e58a14770d/43856_2025_981_Fig3_HTML.jpg

相似文献

1
Appraisal of multiple polygenic risk scores to estimate the risk of myocardial infarction and coronary artery lesions.评估多个多基因风险评分以估计心肌梗死和冠状动脉病变的风险。
Commun Med (Lond). 2025 Jul 1;5(1):264. doi: 10.1038/s43856-025-00981-w.
2
Effects of a gluten-reduced or gluten-free diet for the primary prevention of cardiovascular disease.减少或无麸质饮食对心血管疾病一级预防的影响。
Cochrane Database Syst Rev. 2022 Feb 24;2(2):CD013556. doi: 10.1002/14651858.CD013556.pub2.
3
Familial Hypercholesterolemia家族性高胆固醇血症
4
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
5
Quality improvement strategies for diabetes care: Effects on outcomes for adults living with diabetes.糖尿病护理质量改进策略:对成年糖尿病患者结局的影响。
Cochrane Database Syst Rev. 2023 May 31;5(5):CD014513. doi: 10.1002/14651858.CD014513.
6
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.
7
The effectiveness and cost-effectiveness of computed tomography screening for coronary artery disease: systematic review.计算机断层扫描筛查冠心病的有效性和成本效益:系统评价
Health Technol Assess. 2006 Oct;10(39):iii-iv, ix-x, 1-41. doi: 10.3310/hta10390.
8
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
9
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状Meta分析。
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.
10
Exercise-based cardiac rehabilitation for coronary heart disease.基于运动的冠心病心脏康复
Cochrane Database Syst Rev. 2016 Jan 5;2016(1):CD001800. doi: 10.1002/14651858.CD001800.pub3.

本文引用的文献

1
Imputation Server PGS: an automated approach to calculate polygenic risk scores on imputation servers.PGS 推断服务器:一种在推断服务器上计算多基因风险评分的自动化方法。
Nucleic Acids Res. 2024 Jul 5;52(W1):W70-W77. doi: 10.1093/nar/gkae331.
2
Integration of a polygenic score into guideline-recommended prediction of cardiovascular disease.将多基因风险评分纳入指南推荐的心血管疾病预测中。
Eur Heart J. 2024 May 27;45(20):1843-1852. doi: 10.1093/eurheartj/ehae048.
3
Clinical applications of polygenic risk score for coronary artery disease through the life course.
通过整个生命周期评估多基因风险评分在冠心病中的临床应用。
Atherosclerosis. 2023 Dec;386:117356. doi: 10.1016/j.atherosclerosis.2023.117356. Epub 2023 Oct 18.
4
A multi-ancestry polygenic risk score improves risk prediction for coronary artery disease.多血统多基因风险评分可提高冠心病风险预测。
Nat Med. 2023 Jul;29(7):1793-1803. doi: 10.1038/s41591-023-02429-x. Epub 2023 Jul 6.
5
Genetic, sociodemographic, lifestyle, and clinical risk factors of recurrent coronary artery disease events: a population-based cohort study.基于人群的队列研究:复发性冠心病事件的遗传、社会人口学、生活方式和临床危险因素。
Eur Heart J. 2023 Sep 21;44(36):3456-3465. doi: 10.1093/eurheartj/ehad380.
6
Predictive Utility of a Coronary Artery Disease Polygenic Risk Score in Primary Prevention.冠心病多基因风险评分在一级预防中的预测效用。
JAMA Cardiol. 2023 Feb 1;8(2):130-137. doi: 10.1001/jamacardio.2022.4466.
7
Discovery and systematic characterization of risk variants and genes for coronary artery disease in over a million participants.在超过 100 万名参与者中发现并系统地描述了冠心病的风险变异和基因。
Nat Genet. 2022 Dec;54(12):1803-1815. doi: 10.1038/s41588-022-01233-6. Epub 2022 Dec 6.
8
Systematic comparison of family history and polygenic risk across 24 common diseases.24 种常见疾病的家族史和多基因风险的系统比较。
Am J Hum Genet. 2022 Dec 1;109(12):2152-2162. doi: 10.1016/j.ajhg.2022.10.009. Epub 2022 Nov 7.
9
Association of a Multiancestry Genome-Wide Blood Pressure Polygenic Risk Score With Adverse Cardiovascular Events.多血统全基因组血压多基因风险评分与不良心血管事件的关联。
Circ Genom Precis Med. 2022 Dec;15(6):e003946. doi: 10.1161/CIRCGEN.122.003946. Epub 2022 Nov 5.
10
Advances and Applications of Polygenic Scores for Coronary Artery Disease.冠状动脉疾病多基因评分的进展与应用
Annu Rev Med. 2023 Jan 27;74:141-154. doi: 10.1146/annurev-med-042921-112629. Epub 2022 Oct 31.